Press release
Pharmacogenomics Market Generated Opportunities, Future Scope 2023-2030 | Top Leading Industry Players are Admera Health, Abbott Laboratories, Agilent Technologies and Others
Pharmacogenomics
The Global Pharmacogenomics Market size was valued at USD 13.1 billion in 2021 and is expected to grow by USD 33.1 billion in 2030 at a CAGR of 11.1%.
Request Sample PDF of the Report: https://www.extrapolate.com/sample/Healthcare-Medical-Devices-Biotechnology/pharmacogenomics-market/25959
Pharmacogenomics combines pharmacology (the study of drugs) and genomics (the study of genes and their functions) to identify genetic variations that can influence an individual's response to a drug. By understanding these variations, healthcare professionals can personalize drug therapy and adjust dosage and treatment plans to maximize efficacy and minimize adverse effects.
The Pharmacogenomics market has several key players operating in the industry:
Prominent Companies to Establish Various Corporate Strategies to Aid in Global Expansion. These players are focusing on strategic collaborations and partnerships to expand their market presence and strengthen their product portfolio.
Key Player are covered:
• Admera Health
• Abbott Laboratories.
• Agilent Technologies
• Novartis AG
• Dynamic DNA Laboratories
• Empire Genomics, LLC.
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• OneOme, LLC
• Myriad Genetics Inc.
• OPKO Health, Inc. (GeneDx.)
• Thermo Fisher Scientific, Inc.
• AltheaDx
SEGMENTATION: The market is segmented based on product type, application, end-user, and region.
By Technology
• DNA Sequencing
• Microarray
• Polymerase Chain Reaction
• Electrophoresis
• Mass Spectrometry
By Application
• Drug Discovery
• Neurology
• Oncology
• Pain Management
Inquire Before Buying This Report: https://www.extrapolate.com/enquire/Healthcare-Medical-Devices-Biotechnology/pharmacogenomics-market/25959
Regional Outlook:
• North America
• Middle East and Africa
• Asia-Pacific
• Europe
• South America
Why Purchase the Report?
• The report includes information such as market dynamics scenario, opportunities and challenges during the forecast period
• Identify the key regulations prevailing in the market and understand their impact on the market over the forecast period
• Regional, sub-regional, and country-level data include the demand and supply forces along with their influence on the market.
• The competitive landscape comprises a share of key players, offering products, relevant financial information, recent developments, SWOT analysis, and strategies.
• Understand the current market scenario and viability of the global market over the forecast period.
Browse Complete Report @ https://www.extrapolate.com/Healthcare-Medical-Devices-Biotechnology/pharmacogenomics-market/25959
Some of the key questions answered in this report:
• What can we estimate about the anticipated growth rates and also the global Pharmacogenomics industry size by 2028?
• What will happen in the coming existing and emerging markets?
• What will the market development pace of market?
• Which are the five top players in the Pharmacogenomics market?
• How will the Pharmacogenomics market change in the upcoming years?
KEY INDUSTRY DEVELOPMENTS:
• In September 2021, Abbott, a U.S. multinational medical products and health care corporation acquired the Walk Vascular, LLC, a commercial-stage medical device start up with a minimally invasive mechanical aspiration thrombectomy system intended to remove peripheral blood clots.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
Chapter 3. Market Outlook
Chapter 4. COVID-19 Impact On Diabetes Supplements Market
Chapter 5. Global Diabetes Supplements Market Overview, By Disease Type, 2017 - 2030(USD Million)
Chapter 6. Global Diabetes Supplements Market Overview, By Type, 2017 - 2030(USD Million)
------To be continued
Browse Complete TOC: https://www.extrapolate.com/toc/Healthcare-Medical-Devices-Biotechnology/pharmacogenomics-market/25959
Contact Us
Extrapolate
Phone: (+1) 888 328 2189
E-mail: talk@extrapolate.com
Website: https://www.extrapolate.com
Blog: https://www.extrapolate.com/blog
About Extrapolate
Extrapolate is a Global Market Research, Advisory and Consulting firm which works closely with Industry experts from various industries to bring the latest and most accurate research reports.
In an era of breakneck change and a low tolerance for missed or misread opportunities, businesses need astute guidance to shape markets - not merely respond to them. Extrapolate helps clients develop market perspectives that drive success.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics Market Generated Opportunities, Future Scope 2023-2030 | Top Leading Industry Players are Admera Health, Abbott Laboratories, Agilent Technologies and Others here
News-ID: 2954877 • Views: …
More Releases from Extrapolate
ChatGPT: Your Secret Weapon for Dominating Search Rankings through AI-powered Co …
The ability to do efficient keyword research and content optimization is now essential for anyone looking to succeed online in the information-driven digital age. But fear not; ChatGPT is a formidable friend at our disposal. The way we approach keyword research and content creation is about to change due to this amazing language model that OpenAI created.
Let's look into how to use ChatGPT to improve content optimization tactics, and…
Lead Acid Battery Market Size is Set to Fly High Growth in Years to Come | Leoch …
Market Overview
Lead-acid batteries are the oldest type of rechargeable battery and are commonly used in a variety of applications, including automobiles, boats, uninterruptible power supplies (UPS), and backup power for telecommunications and computer systems.
These batteries consist of lead plates submerged in an electrolyte solution of sulfuric acid and water. During charging, electrical energy is converted into chemical energy, which is stored in the battery as lead sulfate. When the battery…
Onshore Wind Energy Market Size Focus on Emerging Technologies, Top Countries Da …
Market Overview
The Global Onshore Wind Energy Market Size was estimated at USD 554909.73 million in 2021 and is projected to reach USD 2356796.43 million by 2028, exhibiting a CAGR of 22.95% during the forecast period.
Onshore wind energy is a form of renewable energy that involves generating electricity by harnessing the power of wind on land. This is typically done using wind turbines, which convert the kinetic energy of the wind…
Vegetable Seeds Market is expected to witness a substantial growth of around USD …
The global Vegetable seeds market size was valued at approximately USD 8.72 billion in 2022 and is expected to witness a substantial growth of around USD 16.38 billion by 2032 at a CAGR of approximately 6.51% during the period from 2023 to 2032.The vegetable seeds market refers to the global trade of seeds used for growing different types of vegetables, including but not limited to tomatoes, onions, cucumbers, carrots, and…
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
